Force Therapeutics collaborates with ECU Health to Standardize Care, Optimize Patient Engagement
NEW YORK, April 23, 2025 /PRNewswire/ — Force Therapeutics, a surgical episode of care management platform, is proud to announce a new strategic collaboration with North Carolina health system ECU Health. This collaboration provides ECU Health with a highly refined patient engagement platform that enables preoperative optimization, standardization of care pathways, remote delivery of gold-standard education, and automated collection of patient-reported outcome measurements (PROMs) mandated by the Centers for Medicare & Medicaid Services (CMS).
'As part of our commitment to deliver high-quality patient care experiences across eastern North Carolina, we are excited to collaborate with Force Therapeutics to augment our world-class in-person care with effective remote and digital care technology solutions,' said Dustin Allis, vice president of Service Lines at ECU Health.
Comprehensive Digital Care
The integration of Force Therapeutics aligns with ECU Health's mission to improve the health and well-being of eastern North Carolina. The collaboration underscores both organizations' commitment to leveraging effective health tools to drive better health outcomes for all patients.
'We are able to create better health outcomes and more efficient operations by equipping our providers with the tools they need to enhance care provision and fulfill CMS mandates while also empowering patients with the tools and information they need to actively engage in their recovery,' said Dr. Jeffery Garrett, director of Arthroplasty at ECU Health.
Force Therapeutics will support ECU Health in optimizing care delivery by:
Automating the collection of patient data and PROMs to fulfill quality improvement initiatives, ensure CMS compliance, maintain Joint Commission accreditation, and streamline AJRR registry participation.
Optimizing patients' at-home recovery with intelligent digital care instructions, video-based education, and virtual physical therapy.
Automating the care journey, including virtual joint classes, smart alerts, and customizable watch lists that scale provider time.
Reducing readmissions and complications with remote patient monitoring, education, and notifications through the episode of care.
'We are excited to collaborate with ECU Health to drive innovation and further the implementation of quality-focused care,' said Dawna Newman, Head of Client Success & Strategy at Force Therapeutics. 'Our platform is built to supplement in-person care with digital tools to boost patient engagement and satisfaction with clinically validated remote care.'
Learn more about ECU Health and Force Therapeutics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
12-08-2025
- Malaysian Reserve
EasyPA Unleashes Physician-Built AI to Solve $500B Healthcare Bottleneck Ahead of 2026 CMS Deadline
Founded by a team of physicians and AI experts, EasyPA launched the nation's first fully operational prior authorization (PA) platform designed to meet CMS standards two years ahead of the regulatory deadline. The platform directly addresses rising concerns over patient harm, physician burnout, and administrative waste caused by outdated PA systems — delivering real-time, AI-powered approvals and built-in compliance. TAMPA, Fla., Aug. 12, 2025 /PRNewswire/ — Anyone who has experienced delays in care due to the burdensome prior authorization (PA) process from insurers will find relief in EasyPA. Founded by a team of experienced physicians and technologists, this innovative startup is tackling the inefficiencies of healthcare data exchange head-on. EasyPA has launched a fully developed, market-ready solution that streamlines the PA process—well ahead of the deadlines set by Center for Medicare and Medicaid Services' Interoperability and Prior Authorization Rule (CMS0057F), which aims to modernize and reform the U.S. healthcare system and rein in bloat that cost providers an estimated $528 million in 2019. (1) EasyPA was co-founded by three healthcare powerhouses: Dr. Paola Ballester, who is CEO and Medical Director of Utilization Management at a leading children's hospital recognized for evidence-based pediatric care and academic excellence; Alex Vega, a CTO and senior AI engineer with deep expertise in electronic health record integrations and HIPAA-compliant infrastructure; and Dr. Ralph Martello, CPO/COO, a board-certified pediatric hospitalist and expert in clinical workflow automation. Together, they designed an AI-powered prior authorization platform designed by doctors — for doctors. 'The PA process is not just an annoying inefficiency—it's life-threatening,' said Dr. Martello. 'We're watching patients suffer while providers chase outdated faxes and paperwork. We built EasyPA so they don't have to wait another two years for relief.' A Life-Threatening Problem According to the American Medical Association and Medical Society of the State of New York: 94% of physicians report care delays due to PAs; 78% of patients abandon treatment altogether because of those delays; 89% of physicians report burnout from spending at least 12 hours a week managing the red tape of PAs. In some cases, the delay isn't just costly, it's deadly. Denials and holdups have resulted in patient hospitalization, permanent harm, and even death. (2) 'The PA process is not just an annoying inefficiency—it's life-threatening,' said Dr. Martello. 'We're watching patients suffer while providers chase outdated faxes and paperwork. We built EasyPA so they don't have to wait another two years for relief.' Regulatory Push Meets Real-World Action Finalized in January 2024, CMS0057F requires Medicare Advantage, Medicaid, and Affordable Care Act (ACA) members to implement Fast Healthcare Interoperability Resources (FHIR) APIs by March 2026. These interfaces enable different healthcare systems to exchange data using a standardized, web-based approach, shorten decision timelines, and publicly report PA metrics. (3) Yet, many insurers are just beginning to react. In July, for instance, Humana announced plans to eliminate one-third of its PA requirements in response to public pressure. (4) Industry-wide, progress remains slow. 'We have what CMS is calling for, and we have it now,' said Dr. Ballester. 'We've seen policy shifts and insurer promises, but our system can help insurers actually fulfill their promises.' With their inside perspective, the physicians developed technology for real-world use aimed at truly streamlining the approval processes. Their innovation creates efficiencies, breaks down barriers that delay care, and leaves more time for their real priority: Helping the patients. EasyPA is the Antidote to the Delay-and-Denial Cycle Unlike some insurer-built AI tools now under fire for auto-denying care, EasyPA technology is designed to support — not override — physician judgment with a cloud-based platform that includes: AI-generated PA forms aligned to payer documentation policies. Real-time clinical validation and policy matching. One-click appeal creation based on payer-specific criteria. HIPAA-secure, FHIR-ready, plug-and-play design with no IT dependency. 'We're not here to automate denials,' CTO Alex Vega said. 'We're here to automate transparency, speed, and fairness.' Administrative bloat from processing PAs costs the U.S. healthcare system billions each year. Doctors, practitioners, and medical practice offices are forced to hire staff just to chase approvals, creating costly inefficiencies that delay care. (5) EasyPA co-founders believe that delays shouldn't be the default. 'This platform gives time back to providers and puts the patient back in focus, where they should be,' Dr. Ballester said. About EasyPA EasyPA was founded by three visionaries — a pediatric hospitalist, a utilization management director, and an AI engineer — who were tired of watching patients suffer because of bureaucratic red tape of an outdated, manual PA process. So, they built the fix. EasyPA is the first AI-powered platform designed by physicians to eliminate prior authorization bottlenecks — automating approvals, accelerating appeals, and cutting time-to-treatment by more than ten times. HIPAA-secure and CMS compliant out of the box, EasyPA is built on modern infrastructure, ready for FHIR, and seamlessly integrates into provider workflows — no IT department required. EasyPA puts control back in the hands of providers and brings compassion and clarity to the most broken part of healthcare. Fix the system. Keep the care. That's EasyPA. Learn more at Sources: Daly, Rich. 'PriorAuthorization Cost and Time Burdens Increase for Providers, Report Finds.' Healthcare Financial Management Association, 22 Jan. 2020, HFMA, planpaymentandreimbursement/priorauthorizationcostandtimeburdensincreaseforproviders/. American Medical Association. 2023 AMA Prior Authorization (PA) Physician Survey. American Medical Association, Dec. 2023. Centers for Medicare & Medicaid Services. CMS Interoperability and Prior Authorization Final Rule (CMS0057F). 17 Jan. 2024. Rechtin, Jim. 'Humana to Reduce About OneThird of Prior Authorization Requirements.' Reuters, 22 July 2025. Chris Mazzolini, Medical Economics, 2025, 24 Apr. 'Prior Authorization Reform: How It Evolved, Why It Burdens Physicians and Patients, and the Promise of AI.' Media Inquiries: Karla Jo Helms JOTO PR™ 727-777-4629
Malaysian Reserve
04-08-2025
- Malaysian Reserve
Nuna Selected by White House and CMS to Join Landmark Health Tech Ecosystem Initiative
SAN FRANCISCO, Aug. 4, 2025 /PRNewswire/ — Nuna announced its selection to join the Centers for Medicare & Medicaid Services (CMS) Health Tech Ecosystem, a landmark public-private initiative designed to transform healthcare for Americans. The initiative was unveiled at a White House event on Wednesday by President Donald Trump, CMS Administrator Dr. Mehmet Oz, HHS Secretary Robert F. Kennedy Jr., and Amy Gleason, Acting Administrator of DOGE. The event was attended by a select group of healthcare leaders and innovators, including Nuna Founder and CEO, Jini Kim. As part of the ecosystem, Nuna will contribute its expertise to two cornerstone efforts: Conversational AI Assistance and Diabetes & Obesity Prevention and Management. 'We're honored to stand alongside CMS in this bold and necessary step forward in healthcare,' said Jini Kim. 'We believe health isn't just built in the hospital or clinic; it's forged in the small moments of our daily lives. That's why we created Nuna, a trusted digital companion to help people succeed on their health journey, one day at a time.' Nuna's pledge is centered on its AI-powered digital engagement platform. Nuna's app empowers patients to confidently manage their chronic conditions through a combination of 24/7 conversational support, motivating gamification, and direct linkage to their clinical care team. This integrated approach drives powerful results: 72% of users with uncontrolled hypertension achieve control and 73% remain active after six months. By connecting daily patient behavior to the clinical team, Nuna bridges a critical gap in today's healthcare landscape by enabling timely, proactive intervention by care teams for their patients. 'Nuna has been a game changer for patients struggling with chronic conditions,' said David Ansell, MD, of Rush University System for Health and a Nuna development partner. 'It extends care from the clinic to the home and its AI enhanced education engages patients in behavioral change that persists over time. The result being better blood pressure control and improved health behaviors. Early results suggest it can crack the code on chronic disease self-management by engaging people to attend to their health when they are in their homes. This type of tech innovation has great potential to transform primary and preventive care across the US.' About Nuna Nuna is a digital health company dedicated to transforming chronic care by empowering patients and their clinicians. Its AI-driven platform provides personalized, continuous support to help people manage their health and chronic conditions in the moments that matter most. Nuna partners with health systems and health plans to improve patient outcomes, enhance care team efficiency, and reduce the overall cost of care. For more information about Nuna's participation in the CMS Digital Health Ecosystem, visit or contact press@
Malaysian Reserve
01-08-2025
- Malaysian Reserve
MiRus Receives New Technology Add-on Payment (NTAP) for EUROPA™ Posterior Cervical Fusion System
ATLANTA, Aug. 1, 2025 /PRNewswire/ — MiRus has received New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS) for the EUROPA® Posterior Cervical System, based on it's proprietary rhenium alloys, for treatment of the cervical and upper thoracic spine. The EUROPA® PCF system is built around a 2.9 mm MoRe rod which is much smaller than current commercial systems. The lower diameter rod allows low-profile pedicle screw tulips leading to less invasive surgery and less hardware prominence in smaller patients. Although lower diameter, MoRe rods provide a superior level of rigidity, strength, and fatigue resistance which reduces the risk of spine rod fractures compared to current systems. The EUROPA® PCF System was awarded Breakthrough Device Designation by the FDA. 'I have used the 4.5mm MoRe rod TL system for complex cases and have had good results,' stated Han Jo Kim MD, Professor of Orthopedic Surgery at the Hospital for Special Surgery, New York 'There is tremendous potential in what this proprietary alloy (MoRe) can accomplish in spine surgery, offering implants that are lower profile, more durable and stronger.' 'We are pleased that CMS has recognized the EUROPA® PCF System as the superior option for treating the cervical and upper thoracic spine, enabling hospitals to receive reimbursement through the NTAP program and ensuring Medicare patients have access to this breakthrough technology,' commented Mahesh Krishnan, Chief Commercial Officer. 'Currently the rates of spine implant failures and revision surgeries for patients remain unacceptably high,' commented Jordan Bauman, VP of Regulatory and Quality. 'with EUROPA® PCF, spine surgeons will be able to provide durable and less invasive surgery for their cervicothoracic patients. This is another step forward in our mission to provide less invasive and more durable devices across a broad spectrum of disease states.' About MiRus, is a life sciences company headquartered in Atlanta, Georgia that has developed and is commercializing proprietary novel biomaterials and implants that are transforming medicine by making surgeries less invasive and implants safer and more durable. Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements. The EUROPA® Posterior Cervical System is not FDA approved. * MiRus® , EUROPA®, MoRe® are all trademarks of MiRus, LLC. Contact:Pam CowartVP of Clinical Affairspcowart@
